45 Grants (Page 1 of 2)
2021
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA047858-03), $517,184USD, 2019-04-15 -- 2024-02-29
 
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5T32DA024628-12), $214,088USD, 2008-07-01 -- 2025-06-30
 
Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain
Hohmann, Andrea G and SCHWIMMER, LAUREN J
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R44CA241513-02), $915,873USD, 2019-09-25 -- 2023-04-30
2020
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA047858-02), $517,184USD, 2019-04-15 -- 2024-02-29
 
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 2T32DA024628-11), $211,858USD, 2008-07-01 -- 2025-06-30
 
NOS1AP as a novel target for treating pathological pain
COURTNEY, MICHAEL and Hohmann, Andrea G
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA200417-05), $254,519USD, 2016-01-08 -- 2020-12-31
 
Role of CB2 in Analgesic Mechanisms
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA041229-05), $351,000USD, 2016-04-15 -- 2021-01-31
2019
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R01DA047858-01), $517,184USD, 04/15/2019 -- 02/29/2024
 
NOS1AP as a novel target for treating pathological pain
COURTNEY, MICHAEL and Hohmann, Andrea G
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA200417-04), $274,315USD, 01/08/2016 -- 12/31/2020
 
Role of CB2 in Analgesic Mechanisms
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA041229-04), $351,000USD, 04/15/2016 -- 01/31/2021
 
Therapeutic antibodies for treating chemotherapy induced peripheral neuropathic pain
Hohmann, Andrea G and PESCE, GUSTAVO
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R43CA241513-01A1), $299,999USD, 09/25/2019 -- 08/31/2020
2018
NOS1AP as a novel target for treating pathological pain
COURTNEY, MICHAEL and Hohmann, Andrea G
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA200417-03), $254,519USD, 01/08/2016 -- 12/31/2020
 
Role of CB2 in Analgesic Mechanisms
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA041229-03), $315,900USD, 04/15/2016 -- 01/31/2021
2017
A Novel Mechanism for Decreasing Opioid Reward
Hohmann, Andrea G and Rebec, George V
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R21DA042584-02), $196,875USD, 08/15/2016 -- 07/31/2018
 
NOS1AP as a novel target for treating pathological pain
COURTNEY, MICHAEL and Hohmann, Andrea G
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA200417-02), $281,910USD, 01/08/2016 -- 12/31/2020
 
Role of CB2 in Analgesic Mechanisms
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R01DA041229-02), $315,900USD, 04/15/2016 -- 01/31/2021
2016
A Novel Mechanism for Decreasing Opioid Reward
Hohmann, Andrea G and Rebec, George V
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R21DA042584-01), $195,156USD, 08/15/2016 -- 07/31/2018
 
NOS1AP as a novel target for treating pathological pain
COURTNEY, MICHAEL and Hohmann, Andrea G
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA200417-01A1), $295,021USD, 01/08/2016 -- 12/31/2020
 
Role of CB2 in Analgesic Mechanisms
Hohmann, Andrea G and Mackie, Kenneth P
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R01DA041229-01A1), $351,000USD, 04/15/2016 -- 01/31/2021
2014
Protein-protein interaction inhibitors as novel analgesics
Hohmann, Andrea G
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 5R21DA037673-02), $234,000USD, 09/15/2013 -- 08/31/2016
2013
2013 Cannabinoid Function in the CNS Gordon Research Conference & Gordon Research
Hohmann, Andrea G
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R13DA035550-01A1), $40,365USD, 06/01/2013 -- 05/31/2014
 
Protein-protein interaction inhibitors as novel analgesics
Hohmann, Andrea G
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R21DA037673-01A1), $195,000USD, 09/15/2013 -- 08/31/2015
2011
2011 Gordon Research Seminar on Cannabinoid Function in The CNS
Hohmann, Andrea G
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 1R13DA030823-01), $15,000USD, 02/01/2011 -- 01/31/2012
2010
An Animal Model of Therapeutic Self-Medication for Neuropathic Pain
Hohmann, Andrea G
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 7RC1DA028200-02), $396,378USD, 09/30/2009 -- 08/31/2012
 
AN ENDOCANNABINOID MECHANISM FOR STRESS-INDUCED ANALGESIA
Hohmann, Andrea G
National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) (ID: 7R01DA021644-06), $497,570USD, 08/15/2006 -- 05/31/2013